February 6, 2018 05:05 PM EST
Financing
Startups

Tak­ing on lousy side ef­fects of ex­ist­ing meds, NEA-backed Xoc tack­les Parkin­son’s/mi­graines with $30M Se­ries A

Brittany Meiling

New En­ter­prise As­so­ciates is back­ing a start­up near San Jose that’s us­ing old clin­i­cal da­ta — paired with new tech — to come up with nov­el drugs …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times